nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Amine-derived hormones—ASMT—malignant glioma	0.127	0.144	CbGpPWpGaD
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—malignant glioma	0.12	0.136	CbGpPWpGaD
Carbimazole—TPO—Thyroxine biosynthesis—SLC5A5—malignant glioma	0.0951	0.108	CbGpPWpGaD
Carbimazole—TPO—Amine-derived hormones—SLC5A5—malignant glioma	0.0546	0.0619	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF1—malignant glioma	0.0398	0.0451	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—MYB—malignant glioma	0.0363	0.0412	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—CSF1—malignant glioma	0.0344	0.039	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.0272	0.0308	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—ASMT—malignant glioma	0.0177	0.0201	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AREG—malignant glioma	0.0172	0.0195	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—ASMT—malignant glioma	0.0166	0.0189	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—malignant glioma	0.0148	0.0167	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—PDGFB—malignant glioma	0.0144	0.0164	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NOTCH1—malignant glioma	0.0128	0.0145	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EGF—malignant glioma	0.0123	0.014	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—FGF2—malignant glioma	0.0105	0.0119	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP2C18—malignant glioma	0.0103	0.0117	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—malignant glioma	0.0102	0.0116	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00959	0.0109	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00946	0.0107	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00831	0.00942	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0082	0.0093	CbGpPWpGaD
Carbimazole—Myopathy—Temozolomide—malignant glioma	0.00793	0.0673	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00777	0.00881	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC5A5—malignant glioma	0.00761	0.00863	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—malignant glioma	0.00746	0.00845	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—NCOR1—malignant glioma	0.00708	0.00803	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00674	0.00764	CbGpPWpGaD
Carbimazole—TPO—Metabolism—RTEL1—malignant glioma	0.00666	0.00755	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CAT—malignant glioma	0.00561	0.00636	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Temozolomide—malignant glioma	0.00522	0.0443	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00511	0.00579	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.00473	0.00536	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.00413	0.00468	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00407	0.00462	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00397	0.0045	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.0039	0.00442	CbGpPWpGaD
Carbimazole—Liver function test abnormal—Carmustine—malignant glioma	0.00386	0.0327	CcSEcCtD
Carbimazole—TPO—Metabolism—COX8A—malignant glioma	0.00382	0.00433	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.00358	0.00406	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00353	0.004	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00352	0.00399	CbGpPWpGaD
Carbimazole—Pancytopenia—Carmustine—malignant glioma	0.00343	0.0291	CcSEcCtD
Carbimazole—Neutropenia—Carmustine—malignant glioma	0.00338	0.0287	CcSEcCtD
Carbimazole—Pancytopenia—Temozolomide—malignant glioma	0.00332	0.0281	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00329	0.00373	CbGpPWpGaD
Carbimazole—Neutropenia—Temozolomide—malignant glioma	0.00326	0.0277	CcSEcCtD
Carbimazole—TPO—Metabolism—ASMT—malignant glioma	0.00325	0.00368	CbGpPWpGaD
Carbimazole—Stomatitis—Carmustine—malignant glioma	0.00314	0.0266	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.0031	0.00351	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCAN—malignant glioma	0.00306	0.00346	CbGpPWpGaD
Carbimazole—Stomatitis—Temozolomide—malignant glioma	0.00303	0.0257	CcSEcCtD
Carbimazole—Haemoglobin—Carmustine—malignant glioma	0.00291	0.0247	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.00289	0.00328	CbGpPWpGaD
Carbimazole—Haemorrhage—Carmustine—malignant glioma	0.00289	0.0245	CcSEcCtD
Carbimazole—Haemoglobin—Temozolomide—malignant glioma	0.00281	0.0238	CcSEcCtD
Carbimazole—Haemorrhage—Temozolomide—malignant glioma	0.00279	0.0237	CcSEcCtD
Carbimazole—Hepatitis—Temozolomide—malignant glioma	0.00279	0.0237	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.00271	0.00307	CbGpPWpGaD
Carbimazole—Alopecia—Carmustine—malignant glioma	0.00256	0.0217	CcSEcCtD
Carbimazole—Angiopathy—Temozolomide—malignant glioma	0.00254	0.0215	CcSEcCtD
Carbimazole—Alopecia—Temozolomide—malignant glioma	0.00247	0.021	CcSEcCtD
Carbimazole—TPO—Metabolism—IDH2—malignant glioma	0.00246	0.00279	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2B6—malignant glioma	0.00232	0.00263	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.0023	0.00261	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Temozolomide—malignant glioma	0.00226	0.0192	CcSEcCtD
Carbimazole—Leukopenia—Carmustine—malignant glioma	0.00225	0.0191	CcSEcCtD
Carbimazole—Angioedema—Temozolomide—malignant glioma	0.00222	0.0189	CcSEcCtD
Carbimazole—Malaise—Temozolomide—malignant glioma	0.00219	0.0186	CcSEcCtD
Carbimazole—Leukopenia—Temozolomide—malignant glioma	0.00218	0.0185	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00218	0.00247	CbGpPWpGaD
Carbimazole—Myalgia—Carmustine—malignant glioma	0.00214	0.0182	CcSEcCtD
Carbimazole—TPO—Metabolism—IDH1—malignant glioma	0.00212	0.0024	CbGpPWpGaD
Carbimazole—Myalgia—Temozolomide—malignant glioma	0.00207	0.0176	CcSEcCtD
Carbimazole—Arthralgia—Temozolomide—malignant glioma	0.00207	0.0176	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00206	0.0175	CcSEcCtD
Carbimazole—TPO—Metabolism—SPHK1—malignant glioma	0.00205	0.00232	CbGpPWpGaD
Carbimazole—Discomfort—Temozolomide—malignant glioma	0.00205	0.0174	CcSEcCtD
Carbimazole—Infection—Carmustine—malignant glioma	0.00204	0.0173	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—RTEL1—malignant glioma	0.00203	0.0023	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Carmustine—malignant glioma	0.00201	0.0171	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP2C18—malignant glioma	0.00201	0.00228	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.00201	0.00227	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00198	0.00224	CbGpPWpGaD
Carbimazole—Infection—Temozolomide—malignant glioma	0.00197	0.0167	CcSEcCtD
Carbimazole—Nervous system disorder—Temozolomide—malignant glioma	0.00195	0.0165	CcSEcCtD
Carbimazole—Thrombocytopenia—Temozolomide—malignant glioma	0.00194	0.0165	CcSEcCtD
Carbimazole—Skin disorder—Temozolomide—malignant glioma	0.00193	0.0164	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00187	0.0159	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00181	0.0153	CcSEcCtD
Carbimazole—Feeling abnormal—Carmustine—malignant glioma	0.00169	0.0144	CcSEcCtD
Carbimazole—Feeling abnormal—Temozolomide—malignant glioma	0.00164	0.0139	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTT1—malignant glioma	0.00162	0.00184	CbGpPWpGaD
Carbimazole—Body temperature increased—Carmustine—malignant glioma	0.00162	0.0138	CcSEcCtD
Carbimazole—Urticaria—Temozolomide—malignant glioma	0.00158	0.0134	CcSEcCtD
Carbimazole—Body temperature increased—Temozolomide—malignant glioma	0.00157	0.0133	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00157	0.00178	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS1—malignant glioma	0.00152	0.00173	CbGpPWpGaD
Carbimazole—Hypersensitivity—Carmustine—malignant glioma	0.00151	0.0128	CcSEcCtD
Carbimazole—Hypersensitivity—Temozolomide—malignant glioma	0.00146	0.0124	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00145	0.00164	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00143	0.00162	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCHE—malignant glioma	0.00141	0.0016	CbGpPWpGaD
Carbimazole—Pruritus—Temozolomide—malignant glioma	0.0014	0.0119	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.0014	0.00159	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A5—malignant glioma	0.0014	0.00158	CbGpPWpGaD
Carbimazole—Rash—Carmustine—malignant glioma	0.0013	0.011	CcSEcCtD
Carbimazole—Dermatitis—Carmustine—malignant glioma	0.00129	0.011	CcSEcCtD
Carbimazole—Headache—Carmustine—malignant glioma	0.00129	0.0109	CcSEcCtD
Carbimazole—Rash—Temozolomide—malignant glioma	0.00125	0.0106	CcSEcCtD
Carbimazole—Dermatitis—Temozolomide—malignant glioma	0.00125	0.0106	CcSEcCtD
Carbimazole—Headache—Temozolomide—malignant glioma	0.00124	0.0106	CcSEcCtD
Carbimazole—Nausea—Carmustine—malignant glioma	0.00122	0.0104	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00121	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.0012	0.00136	CbGpPWpGaD
Carbimazole—Nausea—Temozolomide—malignant glioma	0.00118	0.01	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—COX8A—malignant glioma	0.00117	0.00132	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—malignant glioma	0.00113	0.00128	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAT—malignant glioma	0.0011	0.00124	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00107	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00104	0.00118	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NCOR1—malignant glioma	0.00103	0.00117	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.00101	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ASMT—malignant glioma	0.000991	0.00112	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000968	0.0011	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCAN—malignant glioma	0.000931	0.00106	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000909	0.00103	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAV1—malignant glioma	0.000843	0.000956	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000836	0.000948	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000818	0.000927	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000772	0.000876	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—malignant glioma	0.000768	0.000871	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—IDH2—malignant glioma	0.000751	0.000851	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—malignant glioma	0.000741	0.00084	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000708	0.000803	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000706	0.0008	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000687	0.000778	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—malignant glioma	0.000675	0.000766	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—IDH1—malignant glioma	0.000646	0.000732	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000625	0.000708	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000612	0.000694	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—malignant glioma	0.000589	0.000667	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—malignant glioma	0.000583	0.000661	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00058	0.000657	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000577	0.000654	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000526	0.000596	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—malignant glioma	0.000509	0.000577	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000507	0.000575	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000495	0.000561	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000464	0.000526	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000462	0.000524	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—malignant glioma	0.000431	0.000489	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000426	0.000483	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000403	0.000457	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000399	0.000452	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—malignant glioma	0.000359	0.000407	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000348	0.000395	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—malignant glioma	0.000343	0.000389	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAT—malignant glioma	0.000334	0.000378	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOR1—malignant glioma	0.000315	0.000357	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—malignant glioma	0.000293	0.000332	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAV1—malignant glioma	0.000257	0.000291	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000246	0.000278	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—malignant glioma	0.000234	0.000265	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—malignant glioma	0.000226	0.000256	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—malignant glioma	0.000206	0.000233	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—malignant glioma	0.000179	0.000203	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—malignant glioma	0.000178	0.000202	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—malignant glioma	0.000155	0.000176	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—malignant glioma	0.000109	0.000124	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—malignant glioma	8.93e-05	0.000101	CbGpPWpGaD
